Johnson & Johnson (NYSE:JNJ), the giant healthcare conglomerate, announced this morning another round of stock buybacks worth $10.0 billion. The company is touted to have “consistently returned value” to investors in the form of …
Johnson & Johnson
Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson & Johnson is a leader in the pharmaceutical, medical device, and …
Johnson & Johnson
JNJ) was downgraded by equities researchers at Vetr from a “buy” rating to a “hold” rating in a research report issued on Monday, May 1st. They currently have a $128.54 price objective on the stock. Vetr‘s price target suggests a potential …
JNJ) stock run-up. Shares in the blue-chip company are up 15% year-to-date with a nice upward trend. The chart definitely shows a good run for J&J. But could there be a roadblock ahead that will put a damper on these steady gains? What …
Johnson & Johnson
Johnson & Johnson (JNJ) was trading at $121.87 on April 20, 2017, with a 50-day moving average of $125.22 and a 200-day moving average of $118.610. That same day, JNJ stock was trading ~11.5% above its 52-week low of $109.32 on …
Johnson & Johnson
JNJ is not a cheap stock, even if you base your analysis on the current $124 price. The table above lists the four largest U.S. pharmaceuticals, and JNJ is the third most expensive, based on PEG ratios. Valuations seem better when you …
Johnson & Johnson
S&P Research maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 14 with "Buy" rating. (ELGX) stock confirmed the flow of -1.31% with the final price of $6.80. Johnson & Johnson comprises approximately 0.9% of HCR …
George Leong: Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive each day. This …
Press coverage about Johnson & Johnson (NYSE:JNJ) has trended positive on Sunday, AlphaOne Sentiment Analysis reports. AlphaOne, a unit of Accern, ranks the sentiment of press coverage by monitoring more than twenty million …